| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 4.55e-03 | 231 | 9 | 2 | GO:0005085 | |
| Domain | Ig_2 | 5.33e-04 | 73 | 9 | 2 | PF13895 | |
| Domain | Immunoglobulin | 3.54e-03 | 190 | 9 | 2 | IPR013151 | |
| Domain | ig | 3.54e-03 | 190 | 9 | 2 | PF00047 | |
| Domain | Ig_sub2 | 5.35e-03 | 235 | 9 | 2 | IPR003598 | |
| Domain | IGc2 | 5.35e-03 | 235 | 9 | 2 | SM00408 | |
| Domain | Ig_sub | 1.64e-02 | 421 | 9 | 2 | IPR003599 | |
| Domain | IG | 1.64e-02 | 421 | 9 | 2 | SM00409 | |
| Domain | IG_LIKE | 2.20e-02 | 491 | 9 | 2 | PS50835 | |
| Domain | Ig-like_dom | 2.30e-02 | 503 | 9 | 2 | IPR007110 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 4.55e-03 | 252 | 6 | 2 | MM15585 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 6.95e-03 | 313 | 6 | 2 | M27867 | |
| Pubmed | 2.08e-05 | 27 | 9 | 2 | 2574151 | ||
| Interaction | BCL11B interactions | 3.67e-04 | 74 | 8 | 2 | int:BCL11B | |
| Interaction | PWWP2A interactions | 3.87e-04 | 76 | 8 | 2 | int:PWWP2A | |
| Interaction | CHD5 interactions | 3.97e-04 | 77 | 8 | 2 | int:CHD5 | |
| Interaction | ZNF219 interactions | 5.43e-04 | 90 | 8 | 2 | int:ZNF219 | |
| Interaction | LIN37 interactions | 5.79e-04 | 93 | 8 | 2 | int:LIN37 | |
| Interaction | SHPRH interactions | 6.30e-04 | 97 | 8 | 2 | int:SHPRH | |
| Interaction | BCL11A interactions | 6.96e-04 | 102 | 8 | 2 | int:BCL11A | |
| Interaction | BACC1 interactions | 7.24e-04 | 104 | 8 | 2 | int:BACC1 | |
| Interaction | LIN9 interactions | 8.24e-04 | 111 | 8 | 2 | int:LIN9 | |
| Interaction | HMGXB4 interactions | 8.54e-04 | 113 | 8 | 2 | int:HMGXB4 | |
| Interaction | MTF2 interactions | 9.30e-04 | 118 | 8 | 2 | int:MTF2 | |
| Interaction | CDK2AP1 interactions | 9.30e-04 | 118 | 8 | 2 | int:CDK2AP1 | |
| Interaction | BRMS1L interactions | 1.04e-03 | 125 | 8 | 2 | int:BRMS1L | |
| Interaction | GATAD1 interactions | 1.14e-03 | 131 | 8 | 2 | int:GATAD1 | |
| Interaction | SUDS3 interactions | 1.32e-03 | 141 | 8 | 2 | int:SUDS3 | |
| Interaction | SIN3B interactions | 1.44e-03 | 147 | 8 | 2 | int:SIN3B | |
| Interaction | MBD2 interactions | 1.72e-03 | 161 | 8 | 2 | int:MBD2 | |
| Interaction | MYBL2 interactions | 1.74e-03 | 162 | 8 | 2 | int:MYBL2 | |
| Interaction | SAP30 interactions | 1.85e-03 | 167 | 8 | 2 | int:SAP30 | |
| Interaction | PHF1 interactions | 1.96e-03 | 172 | 8 | 2 | int:PHF1 | |
| Interaction | MTA3 interactions | 1.98e-03 | 173 | 8 | 2 | int:MTA3 | |
| Interaction | SAP130 interactions | 2.17e-03 | 181 | 8 | 2 | int:SAP130 | |
| Interaction | SMARCA1 interactions | 2.34e-03 | 188 | 8 | 2 | int:SMARCA1 | |
| Interaction | ZNF512B interactions | 2.54e-03 | 196 | 8 | 2 | int:ZNF512B | |
| Interaction | BPTF interactions | 2.56e-03 | 197 | 8 | 2 | int:BPTF | |
| Interaction | ARID4B interactions | 2.61e-03 | 199 | 8 | 2 | int:ARID4B | |
| Interaction | HAT1 interactions | 3.10e-03 | 217 | 8 | 2 | int:HAT1 | |
| Interaction | GATAD2A interactions | 3.30e-03 | 224 | 8 | 2 | int:GATAD2A | |
| Interaction | GATAD2B interactions | 3.93e-03 | 245 | 8 | 2 | int:GATAD2B | |
| Interaction | MTA1 interactions | 5.20e-03 | 283 | 8 | 2 | int:MTA1 | |
| Interaction | MBD3 interactions | 5.64e-03 | 295 | 8 | 2 | int:MBD3 | |
| GeneFamily | Immunoglobulin like domain containing | 3.04e-03 | 193 | 8 | 2 | 594 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-C1ql2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.32e-06 | 114 | 9 | 3 | f48fd7d378626eb7ef972ff1df87dd6149cb355c | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-C1ql2-Excitatory_Neuron.Slc17a7.C1ql2-Cck_(Dentate_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.90e-04 | 129 | 9 | 2 | 08ecebb7f09d105dfdfd2191fc310910d3baec0f | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.61e-04 | 144 | 9 | 2 | e2a2f260f5ebaaef46248d199c407a15ce9d024a | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.23e-04 | 156 | 9 | 2 | 45a05c7a45a3ec8551818ab67f18b3b9553934c1 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.23e-04 | 156 | 9 | 2 | c380142e49b1e4ecacbf37587aafa57f8562b6ad | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 160 | 9 | 2 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 160 | 9 | 2 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 160 | 9 | 2 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | severe-HSPC|severe / disease stage, cell group and cell class | 4.73e-04 | 165 | 9 | 2 | acd837d88ad3786c263f74651a6c0e02fa2fa2c5 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 4.73e-04 | 165 | 9 | 2 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | remission-HSPC|World / disease stage, cell group and cell class | 4.79e-04 | 166 | 9 | 2 | d269ee6f7adb55b05dcb5eaea96629ccb0b2d6e3 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-04 | 167 | 9 | 2 | fe3338f99f94c0dac37e3d649dfdce82e4a56022 | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 4.96e-04 | 169 | 9 | 2 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | COVID-19_Convalescent-Hematopoietic_SC|COVID-19_Convalescent / Disease group, lineage and cell class | 5.02e-04 | 170 | 9 | 2 | 8a73d5334eed1cd9fdcc3ebeae0bdf9f945c228a | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.08e-04 | 171 | 9 | 2 | 172db31a37b72fb87fe5f0f79da51866b90dd1ad | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.08e-04 | 171 | 9 | 2 | a4e13b304ef414722ffdc06560deeab41785e956 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.08e-04 | 171 | 9 | 2 | 2031797d579ce373921affad70da6e50eec13664 | |
| ToppCell | remission-HSPC|remission / disease stage, cell group and cell class | 5.08e-04 | 171 | 9 | 2 | 41b424e58470a2fc25632aea50a37c7c5ea17645 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.14e-04 | 172 | 9 | 2 | 382cb5fea099110eb026a8bba6cf4c28763ea52f | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.14e-04 | 172 | 9 | 2 | da78f7a71b7f05c5c484c9ed19ba37c55d35e870 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.14e-04 | 172 | 9 | 2 | 8fd3db757d54949bd583d5f0eadf63a32342cb9d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Megakaryocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.32e-04 | 175 | 9 | 2 | b85279b9efd72d7074c4226d50ce139a38c0e1c1 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-Megakaryocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.32e-04 | 175 | 9 | 2 | 901f0181a30e5cc609dcada8d8a59f0468df6fa5 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 177 | 9 | 2 | 092a345cb802f183322aa5542341ba2d96d4f06a | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 177 | 9 | 2 | 7ac99ff16df94b4e08d361e3d98a7b3af8d6ee3b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.44e-04 | 177 | 9 | 2 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | PBMC-Convalescent-Hematopoietic|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.56e-04 | 179 | 9 | 2 | 35271a4396a533f6d960ce55d171a32d9d2fd1a4 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|tumor_Lung / Location, Cell class and cell subclass | 5.75e-04 | 182 | 9 | 2 | 243779ba1009097f8fafa1a691e296ec3aeefc04 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 5.94e-04 | 185 | 9 | 2 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.00e-04 | 186 | 9 | 2 | 722da08cd978249a19855fd3ec8ddda780c99d83 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.26e-04 | 190 | 9 | 2 | 64060e4b56ac9989e659c2d5d2a6b6edeba4d8d4 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.33e-04 | 191 | 9 | 2 | 3839bf57419d3ec3d4464277bb33301d2b7d701f | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.33e-04 | 191 | 9 | 2 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.39e-04 | 192 | 9 | 2 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.53e-04 | 194 | 9 | 2 | 216cba1a04b1a24b080322bc950e7fa2dade5ff1 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.53e-04 | 194 | 9 | 2 | 245a3eb6db9c862b73ad34a8cd2898a3688c16f6 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Others-HSPC|COVID-19_Convalescent / Disease, condition lineage and cell class | 6.73e-04 | 197 | 9 | 2 | c1033a1a8b8b5c8569130aa9405a6e8e65ef7bd0 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.93e-04 | 200 | 9 | 2 | f78968d4b4d907094b2c44dcf5ac557ae94e4484 | |
| Drug | Ro 31-8220 | 1.55e-04 | 48 | 9 | 2 | ctd:C064758 | |
| Drug | NSC702818 | 5.96e-04 | 94 | 9 | 2 | CID000148193 | |
| Drug | 1n9a | 6.08e-04 | 95 | 9 | 2 | CID004631604 | |
| Drug | Cortisporin | 2.09e-03 | 177 | 9 | 2 | CID000004454 | |
| Drug | retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 1211_DN | |
| Drug | 3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 4426_UP |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RCHGWRNWDVYKVIY | 131 | P12319 | |
| CHRWVFGWIGCRWYG | 96 | Q6U736 | |
| AGLYRCCYWKETGWS | 101 | Q8N6C5 | |
| GYIGERCQYRDLKWW | 1006 | P01133 | |
| ELWARCLLGHCYGLW | 761 | O75064 | |
| RLCAICWLYWKKYGG | 401 | Q9BTC8 | |
| WVRWHKGRLCLYCGY | 436 | Q8N8U3 | |
| GWRCGYLECSAKYNW | 151 | Q92737 | |
| CVKHWWVRLLYRPYC | 871 | Q149N8 |